Clinical Trial Update: Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

View source ↗

Summary

This clinical trial update describes a study aimed at personalized prediction of tolerance and immunogenicity in patients with Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Victor J Marder, M.D. | Conditions: Hemophilia A | Status: UNKNOWN